Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026

NCT: NCT07667140 · COMPLETED

NCT IDNCT07667140
StatusCOMPLETED
Start Date2026-03-25
Completion2026-04-30
SponsorWSAUD A/S (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities.

Frequently Asked Questions

What is Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026?

Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026 is a clinical trial registered under NCT07667140. Current status: COMPLETED.

What is the status of NCT07667140?

The current status of NCT07667140 (Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026) is: COMPLETED.

When did Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026 start?

Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026 started on 2026-03-25.

Related Devices

K220403Vibe SF Self-Fitting Hearing AidWsaud A/S K233464WSA Self-Fitting Hearing Aid Gen 2Wsaud A/S

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑